financetom
Business
financetom
/
Business
/
United Bancorporation Q3 net income drops 18%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Bancorporation Q3 net income drops 18%
Oct 31, 2025 7:14 AM

Overview

* United Bancorporation Q3 net income falls to $4.2 mln from $5.1 mln last year

* EPS for Q3 declines to $1.29 from $1.45 in the previous year

* Company repurchased 56,000 shares of UBAB stock

Result Drivers

* NET INTEREST MARGIN - Co reports a net interest margin of 4.6% for Q3

* NONPERFORMING ASSETS - Nonperforming assets decreased 48% from prior year

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS $1.29

Q3 Net $4.20

Income mln

Q3 Net 4.60%

Interest

Margin

Analyst Coverage

* The one available analyst rating on the shares is "strong buy"

* The average consensus recommendation for the banks peer group is "buy."

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck, Gilead Sciences Report Positive Data From Phase 2 Trial of Islatravir, Lenacapavir Combination in HIV
Merck, Gilead Sciences Report Positive Data From Phase 2 Trial of Islatravir, Lenacapavir Combination in HIV
Mar 6, 2024
11:31 AM EST, 03/06/2024 (MT Newswires) -- Merck ( MRK ) and Gilead Sciences ( GILD ) said Tuesday that results from week 24 of the phase 2 trial evaluating the combination of islatravir and lenacapavir support the combination therapy's continued development as a potential treatment option for virologically suppressed people with human immunodeficiency virus, or HIV. The potent antiviral...
MOVES-Citigroup hires Don Plaus from BofA to lead private bank in North America
MOVES-Citigroup hires Don Plaus from BofA to lead private bank in North America
Mar 6, 2024
NEW YORK, March 6 (Reuters) - Citigroup ( C/PN ) hired former Merrill Lynch executive Don Plaus as the head of its private bank in North America, according to a memo to staff seen by Reuters on Wednesday. Plaus will start on April 1 and report to Ida Liu, Citi's global head of private banking, she wrote in the memo....
Integra Resources Upsizes Bought Deal Financing to $13 Million
Integra Resources Upsizes Bought Deal Financing to $13 Million
Mar 6, 2024
11:34 AM EST, 03/06/2024 (MT Newswires) -- Integra Resources Corp. ( ITRG ) has upsized its previously announced bought deal offering, to 14.445 million units (from 11.112 million units) at $0.90 apiece, for gross proceeds of $13 million (from $10 million). Each unit will consist of one common share and one-half of one common share purchase warrant. Each warrant will...
Stellantis to invest $6 billion in Brazil by 2030
Stellantis to invest $6 billion in Brazil by 2030
Mar 6, 2024
BRASILIA, March 6 (Reuters) - Carmaker Stellantis will invest 30 billion reais ($6.07 billion) in Brazil between 2025 and 2030, it said on Wednesday, aiming to launch new products and introduce hybrid-flex vehicles in the country. The investment, announced shortly after a meeting between company executives and President Luiz Inacio Lula da Silva, comes as the government tries to reignite...
Copyright 2023-2026 - www.financetom.com All Rights Reserved